Nivolumab vs Warfarin

## Nivolumab vs Warfarin: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Warfarin**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Warfarin**: Inhibits vitamin K epoxide reductase complex.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Warfarin — 20-60 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Warfarin — C19H16O4.

**Molecular Weight**: Nivolumab — N/A; Warfarin — 308.3280 g/mol.

**Type**: Nivolumab — Antibody; Warfarin — Small molecule.